Latest news with #Indenture
Yahoo
6 days ago
- Business
- Yahoo
OHI Group S.A. Announces Consent Solicitation Relating to its U.S.$400,000,000 13.000% Senior Secured Amortizing Notes due 2029 Regulation S Notes: CUSIP L7S61M AB5, ISIN USL7S61MAB59 Rule 144A Notes: CUSIP 67712M AB5, ISIN US67712MAB54
(the "Notes") LUXEMBOURG, July 17, 2025 /PRNewswire/ -- OHI Group S.A. (the "Issuer") announced today that it launched a solicitation (the "Solicitation") for consents (the "Consents") from holders of the Notes (the "Holders") to approve certain amendments and waivers to the indenture dated July 22, 2024 relating to the Notes (as amended or supplemented from time to time, the "Indenture") to (a) provide for a mandatory redemption of $20.0 million aggregate principal amount of Notes at a price of 105%, of the aggregate principal amount of such Notes, plus accrued and unpaid interest and Additional Amounts, if any, to be paid within five (5) Business Days of the Effective Time and (b) permit the Issuer to retain and utilize the remaining $20.0 million of Unutilized Fleet Expansion Proceeds for general corporate purposes without the need to provide any additional security, (ii) waive any Defaults or Events of Default under the Indenture arising as a result of the current Fleet Expansion Mandatory Redemption provisions of the Indenture, and (iii) make any ancillary amendments to the Indenture required to effect the foregoing amendments and waivers (collectively, the "Proposed Amendments and Proposed Waivers"). Adoption of the Proposed Amendments and Proposed Waivers under the Indenture requires the Consents of the Holders of a majority of the aggregate principal amount of the Notes then outstanding (such consents, the "Required Consents"). A Consent may be validly revoked by a Holder at any time prior to, but not on or after, the Effective Time (as defined below) and will automatically terminate and not be effective if the Required Consents are not obtained on or prior to the Expiration Time (as defined below). Assuming the Issuer receives the Required Consents, each present and future Holder will be bound by the Proposed Amendments and Proposed Waivers to the Indenture once they become operative, whether or not such Holder delivered a Consent. The Issuer expects that, promptly after receipt of the Required Consents on or prior to the Expiration Time, it will give notice to BNY Mellon Corporate Trustee Services Limited as trustee under the Indenture (the "Trustee") that the Required Consents have been received (such time, the "Effective Time"), and the Issuer and the Trustee will execute a supplemental indenture to the Indenture, at a convenient time as soon as practicable thereafter. Holders should note that the Effective Time may fall prior to the Expiration Time, and, if so, Holders may not be given prior notice of such Effective Time. The Solicitation will expire at 5:00 p.m., New York time, on July 22, 2025 (such date and time, as the Issuer may extend from time to time in its sole discretion, the "Expiration Time"). The Solicitation is being made solely on the terms and subject to the conditions set forth in the Issuer's consent solicitation statement in respect of the Notes, dated as of July 16, 2025 (the "Consent Solicitation Statement"). The Issuer may, in its sole discretion, terminate, extend or amend the Solicitation at any time as described in the Consent Solicitation Statement. Copies of the Consent Solicitation Statement may be obtained from Kroll Issuer Services Limited, the information and tabulation agent in connection with the Solicitation (the "Information and Tabulation Agent"), at ohigroup@ (Attn: Arlind Bytyqi) or +44 20 7704 0880. Holders of the Notes are urged to review the Consent Solicitation Statement for the detailed terms of the Solicitation and the procedures for consenting to the Proposed Amendments and Proposed Waivers. Holders may also contact Morgan Stanley & Co. LLC, the solicitation agent, in connection with the Solicitation (the "Solicitation Agent") at lmny@ (Attn: Global Debt Advisory Group) or +1 212-761-1057 or +1 800-624-1808. This announcement is for information purposes only and does not constitute an offer to purchase Notes, a solicitation of an offer to sell Notes or a solicitation of consents of Holders and shall not be deemed to be an offer to purchase, a solicitation of an offer to sell or a solicitation of consents with respect to any securities of the Issuer or its affiliates. None of the Issuer, the Trustee, the Information and Tabulation Agent, the Solicitation Agent or any other person makes any recommendation as to whether or not Holders should deliver Consents. Each Holder must make its own decision as to whether or not to deliver Consents. Forward Looking Statements This release may contain forward-looking statements that involve substantial risks and uncertainties. All statements other than statements of historical facts included in this release including, without limitation, statements regarding OHI Group S.A.'s future financial position, risks and uncertainties related to its business, strategy, capital expenditures, projected costs and OHI Group S.A.'s plans and objectives for future operations, may be deemed to be forward-looking statements. Words such as "believe," "expect," "anticipate," "may," "assume," "plan," "intend," "will," "should," "estimate," "risk," and similar expressions or the negatives of these expressions are intended to identify forward-looking statements. By their nature, forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance. You should not place undue reliance on these forward-looking statements. OHI Group S.A. does not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Cautionary Statement Under no circumstances shall the Consent Solicitation Statement constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for the Notes in any jurisdiction. The Solicitation shall not be considered an "offer of securities to the public," or give rise to or require a prospectus in a European Economic Area member state or in the United Kingdom pursuant to Regulation (EU) 2017/1129 (as amended). The Solicitation is not being made to, and no consents are being solicited from, holders or beneficial owners of the Notes in any jurisdiction in which it is unlawful to make such consent solicitation or grant such consents. However, the Issuer may, in its sole discretion and in compliance with any applicable laws, take such actions as it may deem necessary to solicit consents in any jurisdiction and may extend the consent solicitation to, and solicit consents from, persons in such jurisdiction. The communication of the Consent Solicitation Statement and any other documents or materials relating to the Consents (as defined in the Consent Solicitation Statement) is not being made, and such documents and/or materials have not been approved, by an authorised person for the purposes of section 21 of the Financial Services and Markets Act 2000 (the "FSMA"). Accordingly, the Consent Solicitation Statement is not being distributed to, and must not be passed on to, the general public in the United Kingdom. Rather, the communication of the Consent Solicitation Statement as a financial promotion is being made to, and is directed only at: (a) those persons in the United Kingdom falling within the definition of Investment Professionals (contained in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order")) or within Article 43 of the Order, or other persons to whom it may lawfully be communicated in accordance with the Order; or (b) persons outside the United Kingdom. The Consent Solicitation Statement is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which the Consent Solicitation Statement relates is available only to relevant persons and will be engaged in only with relevant persons. The making of the consent solicitation may be restricted by laws and regulations in some jurisdictions. Persons into whose possession the Consent Solicitation Statement comes must inform themselves about and observe these restrictions. This release and the information contained herein are for information purposes only and do not constitute a prospectus or an offer to sell, or a solicitation of an offer to buy or subscribe for, any securities in the United States of America or in any other jurisdiction. For further information, please contact: The Information and Tabulation Agent: Kroll Issuer Services LimitedTel: +44 20 7704 0880E-mail: ohigroup@ Arlind BytyqiConsent Website: The Solicitation Agent Morgan Stanley & Co. LLC585 BroadwayNew York, New York 10036Attention: Global Debt Advisory GroupPhone: +1 212-761-1057 or +1 800-624-1808E-mail: lmny@ View original content: SOURCE OHI Group S.A. Sign in to access your portfolio
Cision Canada
7 days ago
- Business
- Cision Canada
Exro Provides Update on Facility Milestones
CALGARY, AB, July 16, 2025 /CNW/ - Exro Technologies Inc. (TSX: EXRO) (" Exro" or the " Company"), a leading clean technology company specializing in power control solutions for electric vehicles and energy storage, provides a further update on the satisfaction of the near-term strategic milestones established in connection with the company's US$30 million credit facility announced on May 16, 2025 (the " Facility"). Postponement of Debenture Security As the Company announced in its May 16, 2025 news release, advances under the Facility require Exro to meet various milestones, one of which was either (1) the postponement of security from a requisite majority of the Company's $15 million of debentures issued pursuant to an indenture dated December 30, 2022 (the " Convertible Debentures"), or (2) the redemption of the Convertible Debentures for Exro shares. The December 30, 2022 indenture governing the Convertible Debentures (the " Indenture") has been amended to provide that the lender under the Facility has a first priority security interest on substantially all of the assets of the Company, and the Convertible Debentures now have a second priority security position, ranking pari passu with previously issued secured notes of the Company in the aggregate amount of US $70,832,830. In addition, the Indenture was amended to include a 120 day standstill period in respect of the enforcement of certain rights by the holders of the Convertible Debentures on the occurrence of an event of default under the Indenture. The amendments to the Indenture were approved by an extraordinary resolution of over 66 2/3% of the principal outstanding amount of the Convertible Debentures and are contained in an Amended and Restated Indenture dated July 11, 2025, a copy of which has been filed under the Company's profile at Exro thanks the Convertible Debenture holders who supported the Company in this initiative. Strategic Review The strategic review process described in the Company's May 16, 2025 press release remains active and is progressing positively. The Company has received an extension of the Facility milestone of demonstrating active engagement with three credible strategic partners from July 15 to July 31, 2025. ABOUT EXRO TECHNOLOGIES INC. Exro Technologies Inc., now expanded through the strategic acquisition of SEA Electric, is a leading clean technology company that has developed new-generation power control electronics. Its innovative suite of solutions, including Coil Driver™, Cell Driver™, and SEA-Drive®, expand the capabilities of electric motors and batteries and offer OEMs a comprehensive e-propulsion solution with unmatched performance and efficiency. Exro is reshaping global energy consumption, accelerating adoption towards a circular electrified economy by delivering more with less – minimum energy for maximum results. For more information visit our website at To view our Corporate Presentation visit us at Visit us on social media @exrotech. CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS This news release contains forward-looking statements and forward-looking information (together, "forward-looking statements") within the meaning of applicable securities laws. All statements, other than statements of historical facts, are forward-looking statements. Generally, forward-looking statements can be identified using terminology such as "plans", "expects", "estimates", "intends", "anticipates", "believes" or variations of such words, or statements that certain actions, events or results "may", "could", "would", "might", "will be taken", "occur" or "be achieved". Forward looking statements involve risks, uncertainties and other factors disclosed under the heading "Risk Factors" and elsewhere in the Company's filings with Canadian securities regulators, that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Although the Company believes that the assumptions and factors used in preparing these forward-looking statements are reasonable based upon the information currently available to management as of the date hereof, actual results and developments may differ materially from those contemplated by these statements. Readers are therefore cautioned not to place undue reliance on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed times frames or at all. Except where required by applicable law, the Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. This information is qualified in its entirety by cautionary statements and risk factor disclosure contained in filings made by the Company with the Canadian securities regulators, including the Company's annual information form for the financial year ended December 31, 2024, and financial statements and related MD&A for the financial year ended December 31, 2024, filed with the securities regulatory authorities in certain provinces of Canada and available at Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties, and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated, or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law. Neither the Toronto Stock Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this press release.
Yahoo
7 days ago
- Business
- Yahoo
Exro Provides Update on Facility Milestones
CALGARY, AB, July 16, 2025 /CNW/ - Exro Technologies Inc. (TSX: EXRO) ("Exro" or the "Company"), a leading clean technology company specializing in power control solutions for electric vehicles and energy storage, provides a further update on the satisfaction of the near-term strategic milestones established in connection with the company's US$30 million credit facility announced on May 16, 2025 (the "Facility"). Postponement of Debenture Security As the Company announced in its May 16, 2025 news release, advances under the Facility require Exro to meet various milestones, one of which was either (1) the postponement of security from a requisite majority of the Company's $15 million of debentures issued pursuant to an indenture dated December 30, 2022 (the "Convertible Debentures"), or (2) the redemption of the Convertible Debentures for Exro shares. The December 30, 2022 indenture governing the Convertible Debentures (the "Indenture") has been amended to provide that the lender under the Facility has a first priority security interest on substantially all of the assets of the Company, and the Convertible Debentures now have a second priority security position, ranking pari passu with previously issued secured notes of the Company in the aggregate amount of US $70,832,830. In addition, the Indenture was amended to include a 120 day standstill period in respect of the enforcement of certain rights by the holders of the Convertible Debentures on the occurrence of an event of default under the Indenture. The amendments to the Indenture were approved by an extraordinary resolution of over 66 2/3% of the principal outstanding amount of the Convertible Debentures and are contained in an Amended and Restated Indenture dated July 11, 2025, a copy of which has been filed under the Company's profile at Exro thanks the Convertible Debenture holders who supported the Company in this initiative. Strategic Review The strategic review process described in the Company's May 16, 2025 press release remains active and is progressing positively. The Company has received an extension of the Facility milestone of demonstrating active engagement with three credible strategic partners from July 15 to July 31, 2025. ABOUT EXRO TECHNOLOGIES INC. Exro Technologies Inc., now expanded through the strategic acquisition of SEA Electric, is a leading clean technology company that has developed new-generation power control electronics. Its innovative suite of solutions, including Coil Driver™, Cell Driver™, and SEA-Drive®, expand the capabilities of electric motors and batteries and offer OEMs a comprehensive e-propulsion solution with unmatched performance and efficiency. Exro is reshaping global energy consumption, accelerating adoption towards a circular electrified economy by delivering more with less – minimum energy for maximum results. For more information visit our website at To view our Corporate Presentation visit us at Visit us on social media @exrotech. CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS This news release contains forward-looking statements and forward-looking information (together, "forward-looking statements") within the meaning of applicable securities laws. All statements, other than statements of historical facts, are forward-looking statements. Generally, forward-looking statements can be identified using terminology such as "plans", "expects", "estimates", "intends", "anticipates", "believes" or variations of such words, or statements that certain actions, events or results "may", "could", "would", "might", "will be taken", "occur" or "be achieved". Forward looking statements involve risks, uncertainties and other factors disclosed under the heading "Risk Factors" and elsewhere in the Company's filings with Canadian securities regulators, that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Although the Company believes that the assumptions and factors used in preparing these forward-looking statements are reasonable based upon the information currently available to management as of the date hereof, actual results and developments may differ materially from those contemplated by these statements. Readers are therefore cautioned not to place undue reliance on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed times frames or at all. Except where required by applicable law, the Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. This information is qualified in its entirety by cautionary statements and risk factor disclosure contained in filings made by the Company with the Canadian securities regulators, including the Company's annual information form for the financial year ended December 31, 2024, and financial statements and related MD&A for the financial year ended December 31, 2024, filed with the securities regulatory authorities in certain provinces of Canada and available at Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties, and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated, or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law. Neither the Toronto Stock Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this press release. View original content to download multimedia: SOURCE Exro Technologies Inc. View original content to download multimedia:
IOL News
08-07-2025
- General
- IOL News
Professor Kapil Kumar to discuss book 'Revealing Suppressed Realities' at Durban workshop on Girmitiya diaspora
Professor Kapil Kumar from New Delhi will be discussing his book 'Colonial Plantations & Indian Indenturers: Revealing Suppressed Realities' Image: Supplied Professor Kapil Kumar from New Delhi will be discussing his book 'Colonial Plantations & Indian Indenturers: Revealing Suppressed Realities' virtually at the 'The Girmitiya Diaspora in 2025: Identity, challenges and shaping our future' workshop this Saturday. The Global Girmitiya Centre of South Africa is inviting the public to attend the workshop which is set to take place on July 12 at L'Aperitivo - The Auroras, 9 Aurora Dr, Umhlanga Ridge, Durban. The workshop will include participation from: Shri Ravindra Dev (Guyana) – Identity & cohesion, Professor (Dr) Sandili Ramdial- Maharaj (Trinidad) – The psyche of the oppressed & oppressor: Girmitiya experience Professor Kapil Kumar (New Delhi) – Revealing suppressed realities Professor Ganesh Chand (Fiji) – The way forward Bugsy Singh (South Africa) – Girmitiya in SA & facilitation The Global Girmitiya Centre of SA (affiliated to the Global Girmitiya Institute) was established to highlight the South African Girmitiya's history, challenges, heroes and role in the pursuit of social cohesion and nation-building – and to liaise with Girmitiya populations in the diaspora. The book, which Professor Kumar co-edited with fellow participant, Dr Sandili Ramdial-Maharaj from Trinidad, seeks to provide an alternative to the established colonial narrative on Indenture labour history. The book highlights how the plantation economies, to save themselves from ruin after the abolition of slavery, re-packaged it in the form of indentured labour. Professor Kapil Kumar from New Delhi will be discussing his book 'Colonial Plantations & Indian Indenturers: Revealing Suppressed Realities' virtually. Image: Professor Kapil Kumar/Facebook 'To procure it, India was converted into the biggest market. Oppressive practices, deceit, manipulations, false promises and allurements - the established colonial tools were operationalised to facilitate smooth flow of labour under the garb of agreements, converting India into the biggest labour-recruiting nation. 'The agonies of this new human trading were not confined to economic aspects alone. It generated wider and serious social, religious and psychological implications for the Indian community in alien lands, which has been described as the trauma of the Indenturers by Dr. Sandili Maharaj-Ramdial,' a book summary reads. 'This trauma emerged from the recruitment methods, long hard ship journeys, betrayals of so-called agreements, separations from loved ones and the toiling conditions in plantations spread over in Trinidad, Guyana, Suriname, Mauritius and Fijil etc.' Professor Kumar said the reason why he argues that indentured labourers were the same as slaves is that the working conditions did not change. He mentioned that the restrictions placed on them at the colony plantations were the same as that of the slaves. 'A labourer from one plantation could not move to the other plantation without permission. 'And also, the way that families were parted - The husband would go to another plantation while the wife would go to another plantation, and the children would likely be sent to some other place. 'So all these kinds of things, among others, were suppressed in colonial history and geography,' Kumar said. He later added that one of the worst things was how, after its abolishment, when the indentured labourers wanted India to help them, 'they were denied it' and that they were told they 'are not the citizens of India, we can't help you.' 'And the question there is, none of them had given up their Indian citizenship when they went to the other countries, and none had gone on passports or anything. They were refused help.' He added that history is not just the study of the past or the dead, but that it shows how the present has evolved. 'The idea is to let the present generations also know their ancestors toiled to make them what they are today. It is not that the present diaspora, and all its descendants, fell from the sky.'
Cision Canada
02-07-2025
- Business
- Cision Canada
LSL PHARMA GROUP ANNOUNCES REDEMPTION OF 11% UNSECURED CONVERTIBLE DEBENTURES
BOUCHERVILLE, QC, July 2, 2025 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (" LSL Pharma" or the " Corporation"), a Canadian integrated pharmaceutical company, is pleased to announce that TSX Trust Company (the " Trustee"), in accordance with the trust indenture dated November 1, 2023 between the Corporation and the Trustee (the " Indenture"), will be providing notice of early redemption of all of the Corporation's outstanding $3,288,000 aggregate principal amount of 11% convertible unsecured convertible debentures, originally due October 31, 2028 (the " Convertible Debentures"). The Convertible Debentures will be redeemed by the Trustee on August 4, 2025 (the " Redemption Date"), in accordance with the terms of the Indenture. The Convertible Debentures, which are listed and posted for trading on the TSX Venture Exchange (" TSXV") under the symbol will cease trading on the Redemption Date, in accordance with TSXV policies. On the Redemption Date, the Trustee will pay holders of Convertible Debentures a redemption price equal to $10.40 for each $10 principal amount of Convertible Debentures (which includes the early repayment premium required pursuant to the Indenture) plus all accrued and unpaid interest up to but excluding the Redemption Date. Beneficial holders of the Convertible Debentures are encouraged to contact their investment dealer to coordinate the surrender of their Convertible Debentures or if they have any questions about the redemption. No action is required to be taken by holders of the Convertible Debentures in connection with the redemption. ABOUT LSL PHARMA GROUP INC. LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. Companies forming part of LSL Pharma Group include Steri-Med Pharma Inc., LSL Laboratory Inc., Virage Santé Inc. and Dermolab Pharma Ltd. For further information, please visit our website at CAUTION REGARDING FORWARD-LOOKING STATEMENTS This press release may contain forward-looking statements as defined under applicable Canadian securities legislation. Forward-looking statements can generally be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "continue" or similar expressions. Forward-looking statements are based on a number of assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Corporation's ability to control or predict, that could cause actual results or performance to differ materially from those expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, those identified in the Corporation's filings with Canadian securities regulatory authorities, such as legislative or regulatory developments, increased competition, technological change and general economic conditions. All forward-looking statements made herein should be read in conjunction with such documents. Readers are cautioned not to place undue reliance on forward-looking statements. No assurance can be given that any of the events referred to in the forward-looking statements will transpire, and if any of them do, the actual results, performance or achievements of the Corporation may differ materially from those expressed or implied by the forward-looking statements. All forward-looking statements contained in this press release speak only as of the date of this press release. The Corporation does not undertake to update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) have reviewed or accept responsibility for the adequacy or accuracy of this release. SOURCE Groupe LSL PHARMA INC.
